Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial (Trials, (2022), 23, 1, (45), 10.1186/s13063-021-05968-1)

  • Christopher Kai Shun Leung
  • , Seraph Tianmin Ren
  • , Poemen Pui Man Chan
  • , Kelvin Ho Nam Wan
  • , Aziz Ka Wai Kam
  • , Gilda Wing Ki Lai
  • , Vivian Sheung Man Chiu
  • , Match Wai Lun Ko
  • , Cedric Ka Fai Yiu
  • , Marco Chak Yan Yu

Research output: Journal article publicationComment/debate/erratum

1 Citation (Scopus)

Abstract

Following the publication of the original article [1], we were notified that the received date of the paper was 26 November 2020, and not 8 March 2021. The original article has been corrected.

Original languageEnglish
Article number134
JournalTrials
Volume23
Issue number1
DOIs
Publication statusPublished - Dec 2022

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Correction to: Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial (Trials, (2022), 23, 1, (45), 10.1186/s13063-021-05968-1)'. Together they form a unique fingerprint.

Cite this